Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.00
Bid: 321.00
Ask: 322.00
Change: 1.00 (0.31%)
Spread: 1.00 (0.312%)
Open: 322.00
High: 322.00
Low: 321.00
Prev. Close: 321.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Project Helix

19 Mar 2019 15:16

RNS Number : 3441T
Bank of Cyprus Holdings PLC
19 March 2019
 

Announcement

 

Update on Project Helix - Agreement for the sale of a portfolio of non-performing loans

 

 

Nicosia, 19 March 2019

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014

 

 

Further to the announcement of 28 August 20181 in relation to the agreement for the sale of a portfolio of non-performing loans, known as "Project Helix", or the "Transaction", Bank of Cyprus Holdings Public Limited Company ("BOCH" and, together with its subsidiaries, the "Group") announces that it has received approval from the ECB for the Significant Risk Transfer ("SRT") benefit from the Transaction.

This is an important step towards completion of the Transaction, which remains subject to various outstanding conditions precedent1. Completion is currently expected to occur in early 2Q2019.

As previously reported, the Transaction reduces the Group's non-performing exposures (NPEs) by €2.7 bn and improves the NPE ratio from 47% to 36%3. The NPE provisioning coverage ratio pro forma for the Transaction stands at 47%3.

On completion, the derecognition of the Helix portfolio is expected to have a positive impact on the capital ratios of 160 basis points2, resulting from the release of risk weighted assets.

As at 31 December 2018, as previously reported, the Group's phased-in CET1 ratio and Total capital ratio, pro forma for both DTC2 and Helix, stood at 15.4% and 18.3% respectively.

For further information, please contact Investor Relations at investors@bankofcyprus.com.

[1] Further to the announcement of 28 August 2018 and updates provided with the publication of the Group financial results for the nine months ended 30 September 2018 and the preliminary Group financial results for the year ended 31 December 2018

2 Refer to slide 36 of the presentation for the preliminary Group financial results for the year ended 31 December 2018 published on 4 March 2019

3 Based on the preliminary Group financial results for the year ended 31 December 2018

4 DTC refers to the amendments in the legislation adopted by the Cyprus Parliament on 1 March 2019 and was published on the Official Gazette of the Republic on 15 March 2019

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 112 branches in Cyprus. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 4,146 staff worldwide. At 31 December 2018, the Group's Total Assets amounted to €22.1 bn and Total Equity was €2.4 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURLLFLEVVIALIA
Date   Source Headline
26th May 20227:00 amRNSTR1 Notification - Eaton Vance
23rd May 202210:35 amRNSBoard and Board Committees Composition
23rd May 20227:17 amRNSResolutions of AGM- Replacement
20th May 202212:36 pmRNSResolutions of AGM
19th May 20227:02 amRNSDoc re. (1Q2022 Financial Results Presentation)
19th May 20227:00 amRNS1st Quarter Results
5th May 20229:47 amRNSDate of announcement of 1Q2022 FR
14th Apr 20221:06 pmRNSNotice of AGM
13th Apr 202212:41 pmRNSPDMR Transaction - Ioardanou
7th Apr 202212:53 pmRNSPillar 3 Disclosures for 2021
4th Apr 20227:27 amRNSTR1 Notification of Major Holdings- Caius
30th Mar 202210:57 amRNSPDMR Notification of Transaction – Iordanou
30th Mar 20227:05 amRNSBOC Annual Financial Report 2021 Announcement
30th Mar 20227:03 amRNSBOCH Annual Financial Report 2021 Announcement
30th Mar 20227:02 amRNSDoc re. (FY2021 Investor Presentation)
30th Mar 20227:00 amRNSFY2021 Group Financial Results
18th Mar 202211:46 amRNSNotice of Results
17th Mar 20229:37 amRNSRestrictive measures and sanctions against Russia
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Feb 20227:02 amRNSDoc re. Prelim FY2021 Investor Presentation
21st Feb 20227:00 amRNSFY2021 Prel. Group FR and MT Strategic Targets
18th Feb 20228:22 amRNSTR1 Major Holdings Notification -Senvest
8th Feb 20227:00 amRNSDate of announcement of Preliminary Results 2021
13th Jan 20224:40 pmRNSSecond Price Monitoring Extn
13th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Dec 20211:22 pmRNSCompletion of a small-scale targeted VEP
16th Dec 202110:27 amRNSDate of Annual General Meeting
6th Dec 20217:43 amRNSEU-wide Transparency Exercise 2021
1st Dec 20217:00 amRNSDecision to call Tier 2 Capital Notes
30th Nov 202111:51 amRNSAppointment of New Director
30th Nov 202110:32 amRNSGroup Financial Results for 9M2021 - Replacement
30th Nov 20217:04 amRNSDoc re. (9M2021 Presentation Announcement)
30th Nov 20217:00 amRNSGroup Financial Results for 9M2021
19th Nov 20218:25 amRNSDate of Announcement of 9M2021 FR
15th Nov 20217:00 amRNSAgreement for sale of a portfolio of NPLs
8th Nov 20214:41 pmRNSSecond Price Monitoring Extn
8th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Oct 20214:35 pmRNSPrice Monitoring Extension
8th Oct 202112:10 pmRNSBuyback of Tier 2 Capital Notes
7th Oct 202111:57 amRNSAppointment of New Director
30th Sep 20218:32 amRNSTR-1 Notification- Caius
16th Sep 20217:33 amRNSTR-1 Notification -Senvest
13th Sep 202112:00 pmRNSTR-1 Notification - Carval
9th Sep 20214:41 pmRNSSecond Price Monitoring Extn
9th Sep 20214:36 pmRNSPrice Monitoring Extension
8th Sep 20214:40 pmRNSSecond Price Monitoring Extn
8th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20219:13 amRNSTR-1 Notification - Caius
1st Sep 20218:39 amRNSDoc re. (1H2021 Investor Presentation)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.